Task: Answer the multiple-choice question.
Query: Which drug has a 4.997\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCCOC(=O)c1ccc(-n2nnnc2SCC(=O)N2CCCCC2)cc1
b) COc1ccc(N2CC(C(=O)Nc3nnc(Cc4ccccc4)s3)CC2=O)cc1
Answer: a. CCCOC(=O)c1ccc(-n2nnnc2SCC(=O)N2CCCCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOC(=O)c1ccc(-n2nnnc2SCC(=O)N2CCCCC2)cc1
CCCOC(=O)c1ccc(-n2nnnc2SCC(=O)N2CCCCC2)cc1
propyl 4-[5-(2-oxo-2-piperidin-1-ylethyl)sulfanyltetrazol-1-yl]benzoate